Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
Elaine Chiquette,1 Elif A Oral,2 Abhimanyu Garg,3 David Araújo-Vilar,4 Praveen Dhankhar5 1Aegerion Pharmaceuticals, Cambridge, MA, USA; 2Brehm Center for Diabetes Research and Metabolism, Endocrinology and Diabetes Division, Department of Internal Medicine, University of Michigan, Ann Arb...
Guardado en:
Autores principales: | Chiquette E, Oral EA, Garg A, Araújo-Vilar D, Dhankhar P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84500cf4e14d4d949b372aa373f4ab63 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias C, et al.
Publicado: (2020) -
Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin
por: Thewjitcharoen Y, et al.
Publicado: (2020) -
Lipodistrofias primarias: presentación clínica y diagnóstico
por: CORTÉS,VÍCTOR, et al.
Publicado: (2019) -
A New Compound Heterozygous Mutation Of BSCL2 In A Chinese Zhuang Ethnic Family With Congenital Generalized Lipodystrophy
por: Qin Y, et al.
Publicado: (2019) -
Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
por: Vadim V. Klimontov, et al.
Publicado: (2020)